Table 1 Age and sex of the studied groups

Group1 (cancer with FN) (n = 50)

Group 2 (cancer without FN) (n = 25)

Group 3 (healthy controls) (n = 25)

Test

P

Age (years)

 Min.– Max.

1–16

1–17.

1–17

H = 0.6

0.7

 Mean ± SD.

7.12 ± 4.28

6.84 ± 3.9

7.84 ± 4.4

Sex(n,5)

 Male

29 (58%)

12(48%)

11(44%)

χ² = 1.5

0.47

 Female

21(52%)

13(52%)

14 (56%)

Type of malignancy (n, %)

Group1 (cancer with FN) (n = 50)

Group 2 (cancer without FN) (n = 25)

ALL

27 (54%)

14 (56%)

χ2 = 33.758

< 0.001

AML

14 (28%)

8 (32%)

Lymphoblastic lymphoma

9 (18%)

3 (12%)